Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SMART | |||
| 10113 | Registry Identifier | DAIDS-ES |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Community Programs for Clinical Research on AIDS | NETWORK |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on HIV transmission risk behavior among SMART study participants.
It is important to consider the role that HIV infected individuals play in ongoing HIV transmission. Different anti-HIV treatment regimens may lead to variations in HIV transmission risk behavior among HIV infected individuals. HIV infected people with viral loads of less than 1,000 copies/ml are less likely to transmit HIV through heterosexual sex. However, condom use sometimes decreases after individuals start combination antiretroviral therapy (ART); also, some studies have shown an increased rate in acquiring sexually transmitted infections (STIs) following initiation of ART, and those on ART may transmit a drug-resistant strain of HIV. In the SMART study, participants were randomly assigned to one of two treatment groups:
The purpose of this study is to compare how the DC and VS regimens affect HIV transmission risk behavior among SMART study participants.
At baseline, participants will complete a questionnaire about their sexual behavior during the previous 2 months. They will also undergo urine and blood collection for STI testing. These same procedures will occur at Months 4 and 12, then every year thereafter for the first 4 years that a participant is in the parent study. Participants and their physicians will be notified of STI testing results so that patients can be referred to appropriate care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1: DC Group | HIV infected participants who will stop or defer ART until the CD4 cell count drops below 250 cells/mm3 and who discontinue ART when CD4 cell count reaches above 350 cells/mm3. Participants are followed by episodic ART based on CD4 cell count. |
| |
| 2: VS Group | HIV infected participants who continue ART to keep viral loads as low as possible, regardless of CD4 cell count. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Delayed ART | Drug | Participants follow a drug conservation (DC) regimen in which ART is stopped or deferred until CD4 cell count dropped below 250 cells/mm3, initiated until CD4 cell count is at least 350 cells/mm3, and then are followed by episodic ART based on CD4 cell count. |
| Measure | Description | Time Frame |
|---|---|---|
| To compare the DC group to the VS group for HIV transmission and risk behaviors | At the end of study |
| Measure | Description | Time Frame |
|---|---|---|
| To compare the VS group to the DC group on HIV transmission risk behavior in participants who are not on ART at enrollment | At the end of study | |
| To compare the effects of continuing ART in the VS group to stopping ART in the DC group on HIV transmission risk behavior among participants who are on ART at enrollment |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
HIV infected participants with a CD4+ cell count greater than 350 cells/mm3 currently receiving or not receiving ART.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wafaa El-Sadr, MD, MPH | Harlem AIDS Treatment Group, Harlem Hospital Center | Study Chair |
| James Neaton, PhD | CPCRA Statistical and Data Management Center/CCBR | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| AIDS Healthcare Foundation CRS | Beverly Hills | California | 90211 | United States | ||
| UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16327323 | Background | Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Mermin J. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006 Jan 2;20(1):85-92. doi: 10.1097/01.aids.0000196566.40702.28. | |
| 15577652 |
| Label | URL |
|---|---|
| Click here for more information on CPCRA 065 | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Continuous ART | Drug | Group 2 participants follow a viral suppression (VS) regimen in which ART was continued to keep viral loads as low as possible, regardless of CD4 cell count. |
|
| At the end of study |
| To evaluate the correlation between self-reported adherence to ART and HIV transmission risk behavior for participants on ART | At the end of study |
| To compare the DC and VS groups for HIV transmission risk behavior in subgroups defined by age, gender, possible transmission category, HIV RNA level, and baseline genotypic resistance pattern. | At the end of study |
| To evaluate the correlation between self-reported transmission risk behavior and the acquisition of certain sexually transmitted diseases as specified in the protocol. | At the end of study |
| To develop analytic techniques to combine behavioral and biological data into a measure of overall transmission risk | At the end of study |
| Fresno |
| California |
| 93702 |
| United States |
| Dr. M. Estes Med. Practice CRS | Mill Valley | California | 94941-3013 | United States |
| Dr. Robert Scott Med. Practice CRS | Oakland | California | 94609 | United States |
| East Bay AIDS Ctr. CRS | Oakland | California | 94609 | United States |
| Dr. Shawn Hassler Med. Practice CRS | San Francisco | California | 94102 | United States |
| Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS | San Francisco | California | 94110 | United States |
| Dr. Virginia Cafaro Med. Practice CRS | San Francisco | California | 94114-1010 | United States |
| Dr. William Owen Med. Practice CRS | San Francisco | California | 94114-1010 | United States |
| Castro-Mission Health Ctr. CRS | San Francisco | California | 94114 | United States |
| San Francisco VAMC, Infectious Diseases Clinic CRS | San Francisco | California | 94121 | United States |
| UCSF PHP, Gen. Internal Medicine Practice CRS | San Francisco | California | 94143 | United States |
| Beacon Clinic at Boulder CRS | Boulder | Colorado | 80501-4507 | United States |
| Denver Infectious Diseases Consultants CRS | Denver | Colorado | 80204-4507 | United States |
| Kaiser Permanente of Denver CRS | Denver | Colorado | 80204-4507 | United States |
| Univ. of Colorado Health Science Ctr. CRS | Denver | Colorado | 80204-4507 | United States |
| Denver Public Health CRS - INSIGHT | Denver | Colorado | 80204 | United States |
| Denver Public Health CRS | Denver | Colorado | 80204 | United States |
| Eastside Family Health Ctr. CRS | Denver | Colorado | 80205 | United States |
| Denver VAMC CRS | Denver | Colorado | 80220 | United States |
| Western Infectious Disease Consultants CRS | Wheat Ridge | Colorado | 80033 | United States |
| Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS | Washington D.C. | District of Columbia | 20422 | United States |
| Miami VAMC CRS | Miami | Florida | 33125 | United States |
| Atlanta VAMC CRS | Decatur | Georgia | 30033 | United States |
| Harper Hosp., Detroit CRS | Detroit | Michigan | 48201 | United States |
| Wayne State Univ. CRS | Detroit | Michigan | 48201 | United States |
| Wayne State Univ. INSIGHT CRS | Detroit | Michigan | 48201 | United States |
| Detroit Community Health Connection, Inc. CRS | Detroit | Michigan | 48215 | United States |
| McAuley Health Ctr. CRS | Grand Rapids | Michigan | 49503 | United States |
| Cooper Univ. Hosp. CRS | Camden | New Jersey | 08103 | United States |
| Cooper Hospital/Univ. Med. Ctr., The Cooper Early Intervention Program (EIP) CRS | Camden | New Jersey | United States |
| New Jersey Medical School- Adult Clinical Research Ctr. CRS | Newark | New Jersey | 07103 | United States |
| South Jersey Infectious Disease, Cape Clinical Trials CRS | Somers Point | New Jersey | 08244 | United States |
| The Early Intervention Program at Kennedy Hosp. CRS | Voorhees Township | New Jersey | 08043 | United States |
| St. Vincent Hosp. & Med. Ctr. CRS | New York | New York | 10011 | United States |
| Bronx Prevention Center CRS | The Bronx | New York | 10452 | United States |
| Bronx-Lebanon Hosp. Ctr. CRS | The Bronx | New York | 10457 | United States |
| Montefiore Med. Ctr., AIDS Ctr. CRS | The Bronx | New York | 10467 | United States |
| PeaceHealth Med. Group - Hilyard Street Clinic CRS | Eugene | Oregon | 97401 | United States |
| Multnomah County Health Dept., HIV Health Services Ctr. CRS | Portland | Oregon | 97204 | United States |
| Legacy Clinic Good Samaritan CRS | Portland | Oregon | 97210 | United States |
| The Research & Education Group-Portland CRS | Portland | Oregon | 97210 | United States |
| Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS | Portland | Oregon | 97213 | United States |
| Kaiser Immune Deficiency Clinic of Portland CRS | Portland | Oregon | 97227 | United States |
| Legacy Clinic Emanuel CRS | Portland | Oregon | 97227 | United States |
| Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS | Portland | Oregon | 97239 | United States |
| Philadelphia FIGHT - Dr. Jay Kostman CRS | Philadelphia | Pennsylvania | 19107 | United States |
| Temple Univ. School of Medicine CRS | Philadelphia | Pennsylvania | 19140 | United States |
| Albert Einstein Med. Ctr., Immunodeficiency Ctr. CRS | Philadelphia | Pennsylvania | 19141 | United States |
| MediCorp, Infectious Disease Associates CRS | Fredericksburg | Virginia | 22401 | United States |
| Hanover Med. Park (Mechanicsville, VA) CRS | Mechanicsville | Virginia | 23116 | United States |
| Eastern Virginia Med. School, Ctr. for the Comprehensive Care of Immune Deficiency CRS | Norfolk | Virginia | 23507 | United States |
| Petersburg Health Care Alliance CRS | Petersburg | Virginia | 23803 | United States |
| Vernon Harris East End Community Health Ctr. CRS | Richmond | Virginia | 23223 | United States |
| CrossOver Health Ctr. CRS | Richmond | Virginia | 23224 | United States |
| South Richmond Health Care Ctr. CRS | Richmond | Virginia | 23224 | United States |
| Hunter Holmes McGuire VAMC CRS | Richmond | Virginia | 23249 | United States |
| VCU Health Systems, Infectious Disease Clinic CRS | Richmond | Virginia | 23298 | United States |
| Kozal MJ, Amico KR, Chiarella J, Schreibman T, Cornman D, Fisher W, Fisher J, Friedland G. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004 Nov 5;18(16):2185-9. doi: 10.1097/00002030-200411050-00011. |
| 15933836 | Background | Remien RH, Halkitis PN, O'Leary A, Wolitski RJ, Gomez CA. Risk Perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS Behav. 2005 Jun;9(2):167-76. doi: 10.1007/s10461-005-3898-7. |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
Not provided
Not provided